CORMORANT ASSET MANAGEMENT, LP
Adviser information for CORMORANT ASSET MANAGEMENT, LP last updated from Form ADV on March 30th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Partnership |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 14 |
---|---|
Investment Advisory/Research | 6 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 14 | $4.0B |
Non-Discretionary | 0 | $0 |
Total | 14 | $4.0B |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 13 | $4.0B |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | <5 | $9.7M |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 57 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
200 CLARENDON STREET52ND FLOOR
BOSTON
MA
United States
Monday - Friday, 9:00AM - 6:00PM
Tel: 857-702-0370, Fax: 617-507-5905
Chief Compliance Officer
NEB OBRADOVIC
GENERAL COUNSEL
200 CLARENDON STREET
52ND FLOOR
BOSTON
MA
United States
Tel:
857-702-0386
Fax:
617-507-5905
N**@******************M
(Full email address available in API data)
Regulatory Contact
TEDDY WAN
COMP.IANCE ASSOCIATE
200 CLARENDON STREET
52ND FLOOR
BOSTON
MA
United States
Tel:
857-702-0385
Fax:
617-507-5905
T****@******************M
(Full email address available in API data)
Industry Affiliates
CORMORANT ASSET MANAGEMENT PUERTO RICO LLC | Other investment adviser, including financial planners |
CORMORANT GLOBAL HEALTHCARE GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
CORMORANT PRIVATE HEALTHCARE GP II, LLC | Sponsor, GP, manager of pooled investment vehicles |
CORMORANT PRIVATE HEALTHCARE GP III, LLC | Sponsor, GP, manager of pooled investment vehicles |
CORMORANT PRIVATE HEALTHCARE GP IV, LLC | Sponsor, GP, manager of pooled investment vehicles |
CORMORANT PRIVATE HEALTHCARE GP V, LLC | Sponsor, GP, manager of pooled investment vehicles |
CORMORANT PRIVATE HEALTHCARE GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP | Hedge Fund | $1,914.8M | $1.0M | 157 |
CORMORANT PRIVATE HEALTHCARE FUND I, LP | Private Equity Fund | $125.4M | $5.0M | 51 |
CORMORANT PRIVATE HEALTHCARE FUND II, LP | Private Equity Fund | $379.9M | $5.0M | 82 |
CORMORANT PRIVATE HEALTHCARE FUND III, LP | Private Equity Fund | $732.8M | $5.0M | 117 |
CORMORANT PRIVATE HEALTHCARE FUND IV, LP | Private Equity Fund | $498.6M | $5.0M | 94 |
CORMORANT PRIVATE HEALTHCARE FUND V, LP | Private Equity Fund | $361.2M | $5.0M | 40 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
CHEN, BIHUA | Individual | – | MANAGING MEMBER & CHIEF EXECUTIVE OFFICER | 03/2013 | > 75% |
OBRADOVIC, NEBOJSA | Individual | – | CHIEF COMPLIANCE OFFICER & GENERAL COUNSEL | 01/2016 | < 5% |
CORMORANT ASSET MANAGEMENT GP, LLC | Domestic Entity | – | GENERAL PARTNER | 03/2018 | < 5% |
CHEN, BIHUA | Individual | CORMORANT ASSET MANAGEMENT GP, LLC | MANAGING MEMBER | 03/2014 | > 75% |
TRIPP, CALEB, JONATHAN | Individual | – | CHIEF FINANCIAL OFFICER & CHIEF OPERATING OFFICER | 08/2020 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
ABIVAX SA | SPONSORED ADS | 28M | 2M | Chen Bihua |
ALUMIS INC | COM | 29M | 2M | Chen Bihua |
ARCELLX INC | COMMON STOCK | 84M | 2M | Chen Bihua |
ARCUTIS BIOTHERAPEUTICS INC | COM | 23M | 3M | Chen Bihua |
ARRIVENT BIOPHARMA INC | COM | 10M | 515K | Chen Bihua |
AVIDITY BIOSCIENCES INC | COM | 17M | 425K | Chen Bihua |
AXSOME THERAPEUTICS INC | COM | 32M | 400K | Chen Bihua |
BIOHAVEN LTD | COM | 28M | 802K | Chen Bihua |
BIOMEA FUSION INC | COM | 16M | 4M | Chen Bihua |
BRIDGEBIO PHARMA INC | COM | 47M | 2M | Chen Bihua |
CARGO THERAPEUTICS INC | COM | 19M | 1M | Chen Bihua |
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 15M | 2M | Chen Bihua |
CG ONCOLOGY INC | COM | 31M | 975K | Chen Bihua |
COMPASS THERAPEUTICS INC | COM | 2M | 2M | Chen Bihua |
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 92M | 2M | Chen Bihua |
CRINETICS PHARMACEUTICALS IN | COM | 60M | 1M | Chen Bihua |
CULLINAN THERAPEUTICS INC | COM | 20M | 1M | Chen Bihua |
EDGEWISE THERAPEUTICS INC | COM | 54M | 3M | Chen Bihua |
ENGENE HOLDINGS INC | COM | 9M | 1M | Chen Bihua |
EYEPOINT PHARMACEUTICALS INC | COM NEW | 72M | 8M | Chen Bihua |
GH RESEARCH PLC | ORDINARY SHARES | 7M | 593K | Chen Bihua |
HELIX ACQUISITION CORP II | CL A ORD SHS | 30M | 3M | Chen Bihua |
IDEAYA BIOSCIENCES INC | COM | 9M | 245K | Chen Bihua |
IMMUNITYBIO INC | COM | 8M | 1M | Chen Bihua |
INSMED INC | COM PAR $.01 | 45M | 675K | Chen Bihua |
JANUX THERAPEUTICS INC | COM | 44M | 1M | Chen Bihua |
KORRO BIO INC | COM | 9M | 266K | Chen Bihua |
LANTHEUS HLDGS INC | COM | 6M | 75K | Chen Bihua |
LONGBOARD PHARMACEUTICALS IN | COM | 75M | 3M | Chen Bihua |
MERSANA THERAPEUTICS INC | COM | 5M | 3M | Chen Bihua |
MERUS N V | COM | 50M | 840K | Chen Bihua |
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 373M | 8M | Chen Bihua |
NEUROGENE INC | COM | 4M | 107K | Chen Bihua |
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | 44M | 2M | Chen Bihua |
PHARVARIS N V | COM | 28M | 1M | Chen Bihua |
PRAXIS PRECISION MEDICINES I | COM NEW | 28M | 685K | Chen Bihua |
RAPPORT THERAPEUTICS INC | COM | 68M | 3M | Chen Bihua |
RAPT THERAPEUTICS INC | COM | 2M | 497K | Chen Bihua |
RHYTHM PHARMACEUTICALS INC | COM | 20M | 475K | Chen Bihua |
SAREPTA THERAPEUTICS INC | COM | 20M | 125K | Chen Bihua |
SIGA TECHNOLOGIES INC | COM | 4M | 500K | Chen Bihua |
SILENCE THERAPEUTICS PLC | ADS | 12M | 625K | Chen Bihua |
STOKE THERAPEUTICS INC | COM | 6M | 427K | Chen Bihua |
TARSUS PHARMACEUTICALS INC | COM | 14M | 500K | Chen Bihua |
UROGEN PHARMA LTD | COM | 28M | 2M | Chen Bihua |
VAXCYTE INC | COM | 83M | 1M | Chen Bihua |
VERVE THERAPEUTICS INC | COM | 2M | 350K | Chen Bihua |
VYNE THERAPEUTICS INC | COM | 3M | 1M | Chen Bihua |
Y-MABS THERAPEUTICS INC | COM | 18M | 1M | Chen Bihua |